Dr. Reddy's launches pre-filled naloxone syringesNaloxone hydrochloride injection had a market value of roughly $31 million for the most recent 12 months ended January 2020, according to IQVIA. Dr. Reddy's launches 1st generic of Geodon for injectionThe Geodon for injection brand had a market value of approximately $21.8 million for the most recent 12 months ended January 2020, according to IQVIA. Amneal names CFO Tasos Konidaris succeeds Todd Branning as Amneal's senior vice president and chief financial officer. IQVIA report: Global medicine spending to top $1.1T by 2024 IQVIA reports that global use of medicine has increased at a 3% compound annual growth rate since 2014, slowing from a 4% rate from 2009–2014. Teva, Celltrion Healthcare launch Herceptin biosimilar Herzuma Teva and Celltrion Healthcare's Herzuma for injection is a biosimilar to Genentech’s Herceptin. Hikma launches generic Zortress Everolimus tablets had a market value of roughly $150 million in the 12 months ended January 2020, according to IQVIA. Lupin launches authorized generic of Vimovo Naproxen and esomeprazole magnesium delayed-release tablets had a market value of roughly $400 million, according to IQVIA January 2020 data. Study: Expanding biosimilar use could reduce patient costs Biosimilars could reduce patient's out-of-pocket costs by 17%, according to a new study by the Center for Medical Economics at the Pacific Research Institute. Mylan launches generic Advair Diskus in Canada Advair Diskus had a market value of $113.9 million in Canada for the 12 months ended Dec. 31, 2019, according to IQVIA. Zydus Cadila's generic Truvada gets FDA green light Zydus Cadila has received the FDA's nod for generic Truvada 200 mg/300 mg, and tentative approval for additional dosage strengths. First Previous 146 147 148 149 150 Next Last